Tag Archives: Biotech and Pharmaceuticals

Johnson & Johnson’s coronavirus vaccine trial is paused after ‘adverse event’ in a participant

Johnson & Johnson’s late-stage coronavirus vaccine was paused after a participant reported an “adverse event” about 36 hours earlier, the company’s chief financial officer said Tuesday. The pause will allow the data and safety monitoring board to thoroughly investigate the unexplained illness, CFO Joseph Wolk said in an interview on CNBC’s “Squawk Box.” “We’re letting… Read More »

Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant

Budrul Chukrut | LightRocket | Getty Images The study of Johnson & Johnson’s Covid-19 vaccine has been paused due to an unexplained illness in a study participant. A document sent to outside researchers running the 60,000-patient clinical trial states that a “pausing rule” has been met, that the online system used to enroll patients in… Read More »

Dr. Fauci says U.S. faces ‘a whole lot of trouble’ as coronavirus cases rise heading into winter

The United States is “facing a whole lot of trouble” as coronavirus cases continue to surge across the country heading into the cold winter months, Dr. Anthony Fauci, the nation’s top infectious disease expert, told CNBC on Monday.  The U.S. reported more than 44,600 new cases on Sunday and the seven-day average rose to over… Read More »

Gilead CEO: ‘We have ample supply’ of remdesivir for hospitalized coronavirus patients

[ad_1] Gilead Sciences will have sufficient global supply of its coronavirus treatment remdesivir by the end of October, CEO Daniel O’Day told CNBC on Friday.  The comments come shortly after the publication of peer-reviewed final data from Gilead’s large-scale trial of remdesivir. It showed the antiviral drug helped Covid-19 patients who are hospitalized recover five days faster… Read More »

Regeneron requests emergency approval for antibody treatment taken by Trump; stock rises 4% in pre-market

[ad_1] Medical technicians work at a drive-through coronavirus disease (COVID-19) testing facility at the Regeneron Pharmaceuticals company’s Westchester campus in Tarrytown, New York, September 17, 2020. Brendan McDermid | Reuters Regeneron‘s stock price rose over 4% in pre-market trade Thursday, as it submitted an “emergency use authorization” (EUA) request to the U.S. Food and Drug… Read More »

Plexiglass barriers at Pence-Harris debate ‘are a joke,’ won’t stop coronavirus, medical experts say

[ad_1] The Commission on Presidential Debates is taking extra precautions at Wednesday night’s vice presidential debate given the coronavirus outbreak in the White House, but pictures of two curved plexiglass barriers they plan to use has some epidemiologists and airborne pathogen specialists scratching their heads. Vice President Mike Pence, a Republican, and Sen. Kamala Harris, a… Read More »

Trump’s use of Regeneron’s experimental coronavirus treatment creates ‘very tough situation,’ CEO says